3.7M XNYS Volume
XNYS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 9,500 | 9,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 67.96 per share. | 13 Mar 2025 | 9,500 | 46,935 (0%) | 0% | 68.0 | 645,624 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Mar 2025 | 9,500 | 56,435 (0%) | 0% | 45.3 | 430,129 | Common Stock |
| Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 10 Mar 2025 | 7,463 | 66,545 (0%) | 0% | 45.3 | 337,900 | Common Stock |
| Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 7,463 | 7,462 | - | - | Employee Stock Option (Right to Acquire) | |
| Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Mar 2025 | 1,299 | 10,436 (0%) | 0% | 0 | Common Stock | |
| Bernard J. Zovighian | Director, CEO | Sale of securities on an exchange or to another person at price $ 69.51 per share. | 10 Mar 2025 | 6,164 | 59,082 (0%) | 0% | 69.5 | 428,448 | Common Stock |
| Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Mar 2025 | 1,299 | 65,246 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Lippis | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 69.48 per share. | 10 Mar 2025 | 400 | 22,588 (0%) | 0% | 69.5 | 27,792 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 400 | 630 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 10 Mar 2025 | 400 | 22,988 (0%) | 0% | 45.3 | 18,111 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 11,250 | 22,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 28 Feb 2025 | 11,250 | 41,637 (0%) | 0% | 45.3 | 509,363 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 71.38 per share. | 28 Feb 2025 | 3,490 | 38,147 (0%) | 0% | 71.4 | 249,123 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 70.52 per share. | 28 Feb 2025 | 7,760 | 30,387 (0%) | 0% | 70.5 | 547,204 | Common Stock |
| Andrew M. Dahl | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.30 per share. | 22 Feb 2025 | 176 | 4,684 (0%) | 0% | 73.3 | 12,901 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.19 per share. | 16 Feb 2025 | 333 | 198,192 (0%) | 0% | 76.2 | 25,371 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.19 per share. | 16 Feb 2025 | 174 | 30,387 (0%) | 0% | 76.2 | 13,257 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.19 per share. | 16 Feb 2025 | 214 | 22,975 (0%) | 0% | 76.2 | 16,305 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.19 per share. | 16 Feb 2025 | 222 | 22,588 (0%) | 0% | 76.2 | 16,914 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.19 per share. | 16 Feb 2025 | 165 | 22,810 (0%) | 0% | 76.2 | 12,571 | Common Stock |
| Steven R. Loranger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.32 per share. | 14 Feb 2025 | 5,739 | 66,111 (0%) | 0% | 45.3 | 260,073 | Common Stock |
| Steven R. Loranger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 5,739 | 0 | - | - | Director Stock Option (Right to Acquire) | |
| Steven R. Loranger | Director | Sale of securities on an exchange or to another person at price $ 76.42 per share. | 14 Feb 2025 | 5,739 | 60,372 (0%) | 0% | 76.4 | 438,576 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Feb 2025 | 6,500 | 53,435 (0%) | 0% | 45.3 | 294,299 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 6,500 | 19,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 75.74 per share. | 13 Feb 2025 | 6,400 | 46,935 (0%) | 0% | 75.7 | 484,737 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 76.26 per share. | 13 Feb 2025 | 100 | 53,335 (0%) | 0% | 76.3 | 7,626 | Common Stock |
| Leslie Stone Heisz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 5,739 | 0 | - | - | Director Stock Option (Right to Acquire) | |
| Leslie Stone Heisz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.32 per share. | 13 Feb 2025 | 5,739 | 35,774 (0%) | 0% | 45.3 | 260,073 | Common Stock |
| Leslie Stone Heisz | Director | Sale of securities on an exchange or to another person at price $ 75.86 per share. | 13 Feb 2025 | 5,739 | 30,035 (0%) | 0% | 75.9 | 435,371 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.76 per share. | 13 Feb 2025 | 11,250 | 30,561 (0%) | 0% | 75.8 | 852,272 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Feb 2025 | 11,250 | 41,811 (0%) | 0% | 45.3 | 509,363 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 11,250 | 33,750 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 76.34 per share. | 13 Feb 2025 | 500 | 23,189 (0%) | 0% | 76.3 | 38,170 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 500 | 1,030 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Feb 2025 | 500 | 23,689 (0%) | 0% | 45.3 | 22,638 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 16 Jan 2025 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 68.75 per share. | 16 Jan 2025 | 5,000 | 46,935 (0%) | 0% | 68.7 | 343,736 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 5,000 | 25,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 16 Jan 2025 | 500 | 23,689 (0%) | 0% | 45.3 | 22,638 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 68.76 per share. | 16 Jan 2025 | 500 | 23,189 (0%) | 0% | 68.8 | 34,382 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 500 | 1,530 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 16 Dec 2024 | 2,500 | 25,689 (0%) | 0% | 45.3 | 113,192 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 2,500 | 2,030 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 74.08 per share. | 16 Dec 2024 | 2,500 | 23,189 (0%) | 0% | 74.1 | 185,196 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 09 Dec 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 5,000 | 30,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 71.75 per share. | 09 Dec 2024 | 5,000 | 46,935 (0%) | 0% | 71.8 | 358,751 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 09 Dec 2024 | 11,250 | 41,811 (0%) | 0% | 45.3 | 509,363 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 11,250 | 45,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 71.68 per share. | 09 Dec 2024 | 11,250 | 30,561 (0%) | 0% | 71.7 | 806,406 | Common Stock |
| Daveen Chopra | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 73.27 per share. | 06 Dec 2024 | 1,750 | 27,583 (0%) | 0% | 73.3 | 128,223 | Common Stock |
| Wayne Markowitz | GM & SVP, Surgical | Sale of securities on an exchange or to another person at price $ 73.27 per share. | 06 Dec 2024 | 583 | 9,493 (0%) | 0% | 73.3 | 42,716 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Nov 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 65.57 per share. | 13 Nov 2024 | 5,000 | 46,935 (0%) | 0% | 65.6 | 327,843 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2024 | 5,000 | 35,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 65.91 per share. | 05 Nov 2024 | 25,000 | 198,525 (0%) | 0% | 65.9 | 1,647,863 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 15 Oct 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 69.51 per share. | 15 Oct 2024 | 5,000 | 46,935 (0%) | 0% | 69.5 | 347,534 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 5,000 | 40,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Wayne Markowitz | GM & SVP, Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.52 per share. | 14 Sep 2024 | 648 | 10,033 (0%) | 0% | 68.5 | 44,401 | Common Stock |
| Andrew M. Dahl | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 2,920 | 4,690 (0%) | 0% | 0 | Common Stock | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 11 Sep 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 5,000 | 45,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 66.77 per share. | 11 Sep 2024 | 5,000 | 46,935 (0%) | 0% | 66.8 | 333,826 | Common Stock |
| Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.96 per share. | 03 Sep 2024 | 5,530 | 81,287 (0%) | 0% | 70.0 | 386,879 | Common Stock |
| Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 10,910 | 86,817 (0%) | 0% | 0 | Common Stock | |
| Daveen Chopra | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 69.95 per share. | 20 Aug 2024 | 1,250 | 29,333 (0%) | 0% | 70.0 | 87,438 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 14 Aug 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2024 | 5,000 | 50,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 66.08 per share. | 14 Aug 2024 | 5,000 | 46,935 (0%) | 0% | 66.1 | 330,420 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 11 Jul 2024 | 500 | 23,689 (0%) | 0% | 45.3 | 22,638 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 500 | 4,530 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 94.18 per share. | 11 Jul 2024 | 500 | 23,189 (0%) | 0% | 94.2 | 47,090 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 10 Jul 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2024 | 5,000 | 55,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 93.29 per share. | 10 Jul 2024 | 5,000 | 46,935 (0%) | 0% | 93.3 | 466,474 | Common Stock |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2024 | 2,308 | 2,308 (0%) | 0% | 0 | Common Stock | |
| Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 07 Jul 2024 | 258 | 75,907 (0%) | 0% | 92.3 | 23,819 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 07 Jul 2024 | 82 | 184,685 (0%) | 0% | 92.3 | 7,570 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 07 Jul 2024 | 410 | 23,189 (0%) | 0% | 92.3 | 37,851 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.11 per share. | 20 Jun 2024 | 400 | 35,786 (0%) | 0% | 88.1 | 35,245 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.47 per share. | 20 Jun 2024 | 5,225 | 30,561 (0%) | 0% | 87.5 | 457,013 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 20 Jun 2024 | 5,625 | 36,186 (0%) | 0% | 45.3 | 254,681 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,625 | 56,250 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 535 | 5,030 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 20 Jun 2024 | 535 | 23,512 (0%) | 0% | 90 | 48,150 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 20 Jun 2024 | 535 | 24,047 (0%) | 0% | 45.3 | 24,223 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 87.54 per share. | 12 Jun 2024 | 5,000 | 46,935 (0%) | 0% | 87.5 | 437,697 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 5,000 | 60,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 12 Jun 2024 | 5,000 | 51,935 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Bernard J. Zovighian | Director, CEO | Sale of securities on an exchange or to another person at price $ 87.68 per share. | 30 May 2024 | 8,617 | 68,217 (0%) | 0% | 87.7 | 755,539 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.45 per share. | 21 May 2024 | 5,625 | 30,561 (0%) | 0% | 90.5 | 508,803 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 5,625 | 61,875 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 21 May 2024 | 5,625 | 36,186 (0%) | 0% | 45.3 | 254,681 | Common Stock |
| Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 11 May 2024 | 827 | 76,165 (0%) | 0% | 86.7 | 71,717 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 11 May 2024 | 985 | 223,525 (0%) | 0% | 86.7 | 85,419 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 11 May 2024 | 1,198 | 30,561 (0%) | 0% | 86.7 | 103,891 | Common Stock |
| Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 11 May 2024 | 229 | 17,081 (0%) | 0% | 86.7 | 19,859 | Common Stock |
| Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 11 May 2024 | 2,854 | 76,834 (0%) | 0% | 86.7 | 247,499 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.71 per share. | 11 May 2024 | 21 | 184,767 (0%) | 0% | 86.7 | 1,821 | Common Stock |
| Daveen Chopra | CVP, TMTT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 11 May 2024 | 821 | 30,583 (0%) | 0% | 86.7 | 71,197 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 11 May 2024 | 377 | 23,512 (0%) | 0% | 86.7 | 32,693 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 10 May 2024 | 814 | 46,935 (0%) | 0% | 86.7 | 70,590 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 87.81 per share. | 10 May 2024 | 5,000 | 47,749 (0%) | 0% | 87.8 | 439,038 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 5,000 | 65,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 10 May 2024 | 5,000 | 52,749 (0%) | 0% | 45.3 | 226,384 | Common Stock |
| Kieran T. Gallahue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 3,055 | 3,055 (0%) | 0% | 0 | Common Stock | |
| Kieran T. Gallahue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 999 | 4,054 (0%) | 0% | 0 | Common Stock | |
| Nicholas J. Valeriani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 4,818 | 73,732 (0%) | 0% | 0 | Common Stock | |
| Paul A. Laviolette | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 3,055 | 10,773 (0%) | 0% | 0 | Common Stock | |
| Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 3,055 | 59,373 (0%) | 0% | 0 | Common Stock | |
| Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 999 | 60,372 (0%) | 0% | 0 | Common Stock | |
| Leslie Stone Heisz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 3,055 | 30,035 (0%) | 0% | 0 | Common Stock | |
| Ramona Sequeira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 3,055 | 8,158 (0%) | 0% | 0 | Common Stock | |
| Leslie C. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 3,055 | 3,055 (0%) | 0% | 0 | Common Stock | |
| Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 32,025 | 77,601 (0%) | 0% | 0 | Common Stock | |
| Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 609 | 76,992 (0%) | 0% | 85.1 | 51,820 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 619 | 47,749 (0%) | 0% | 85.1 | 52,671 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 6,700 | 48,368 (0%) | 0% | 0 | Common Stock | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 6,700 | 6,700 | - | - | Performance Rights | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 39,600 | 39,600 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 51,700 | 51,700 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 8,725 | 225,205 (0%) | 0% | 0 | Common Stock | |
| Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 695 | 224,510 (0%) | 0% | 85.1 | 59,138 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 8,725 | 8,725 | - | - | Performance Rights | |
| Scott B. Ullem | CVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 65,500 | 65,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 11,075 | 32,549 (0%) | 0% | 0 | Common Stock | |
| Scott B. Ullem | CVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 790 | 31,759 (0%) | 0% | 85.1 | 67,221 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 11,075 | 11,075 | - | - | Performance Rights | |
| Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 4,820 | 4,820 | - | - | Employee Stock Option (Right to Acquire) | |
| Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 178 | 17,310 (0%) | 0% | 85.1 | 15,146 | Common Stock |
| Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 2,445 | 17,488 (0%) | 0% | 0 | Common Stock | |
| Bernard J. Zovighian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 33,500 | 80,335 (0%) | 0% | 0 | Common Stock | |
| Bernard J. Zovighian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 33,500 | 33,500 | - | - | Performance Rights | |
| Bernard J. Zovighian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 178,400 | 178,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 647 | 79,688 (0%) | 0% | 85.1 | 55,053 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 7,125 | 7,125 | - | - | Performance Rights | |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 7,125 | 184,834 (0%) | 0% | 0 | Common Stock | |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 46 | 184,788 (0%) | 0% | 85.1 | 3,914 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 42,200 | 42,200 | - | - | Employee Stock Option (Right to Acquire) | |
| Daveen Chopra | CVP, TMTT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 7,000 | 31,851 (0%) | 0% | 0 | Common Stock | |
| Daveen Chopra | CVP, TMTT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 7,000 | 7,000 | - | - | Performance Rights | |
| Daveen Chopra | CVP, TMTT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 37,200 | 37,200 | - | - | Employee Stock Option (Right to Acquire) | |
| Daveen Chopra | CVP, TMTT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 447 | 31,404 (0%) | 0% | 85.1 | 38,035 | Common Stock |
| Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 17,800 | 17,800 | - | - | Employee Stock Option (Right to Acquire) | |
| Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 3,350 | 3,350 | - | - | Performance Rights | |
| Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 3,350 | 10,648 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Lippis | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 15,500 | 15,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 2,900 | 24,475 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 07 May 2024 | 857 | 25,332 (0%) | 0% | 36.8 | 31,495 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 586 | 24,746 (0%) | 0% | 85.1 | 49,863 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 85.60 per share. | 07 May 2024 | 857 | 23,889 (0%) | 0% | 85.6 | 73,359 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 4,660 | 21,575 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Lippis | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 2,900 | 2,900 | - | - | Performance Rights | |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 857 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 479 | 43,222 (0%) | 0% | 85.1 | 40,744 | Common Stock |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 5,796 | 0 | - | - | Performance Rights | |
| Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 3,442 | 45,576 (0%) | 0% | 85.3 | 293,431 | Common Stock |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 5,796 | 49,018 (0%) | 0% | 0 | Common Stock | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 479 | 39,288 (0%) | 0% | 85.1 | 40,744 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 5,855 | 0 | - | - | Performance Rights | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 3,475 | 41,668 (0%) | 0% | 85.3 | 296,244 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 5,855 | 45,143 (0%) | 0% | 0 | Common Stock | |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 6,675 | 0 | - | - | Performance Rights | |
| Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 3,541 | 216,480 (0%) | 0% | 85.2 | 301,870 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 6,675 | 220,021 (0%) | 0% | 0 | Common Stock | |
| Larry L. Wood | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 395 | 213,346 (0%) | 0% | 85.1 | 33,599 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 634 | 18,440 (0%) | 0% | 85.1 | 53,928 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 7,465 | 25,905 (0%) | 0% | 0 | Common Stock | |
| Scott B. Ullem | CVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 4,431 | 21,474 (0%) | 0% | 85.3 | 377,743 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 7,465 | 0 | - | - | Performance Rights | |
| Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 120 | 15,043 (0%) | 0% | 85.3 | 10,230 | Common Stock |
| Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 106 | 15,163 (0%) | 0% | 85.1 | 9,016 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 259 | 177,709 (0%) | 0% | 85.3 | 22,080 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 4,157 | 0 | - | - | Performance Rights | |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.05 per share. | 03 May 2024 | 37 | 173,811 (0%) | 0% | 85.1 | 3,147 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 4,157 | 177,968 (0%) | 0% | 0 | Common Stock | |
| Daveen Chopra | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 4,713 | 27,172 (0%) | 0% | 0 | Common Stock | |
| Daveen Chopra | CVP, TMTT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 291 | 22,459 (0%) | 0% | 85.1 | 24,752 | Common Stock |
| Daveen Chopra | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 4,713 | 0 | - | - | Performance Rights | |
| Daveen Chopra | CVP, TMTT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 2,321 | 24,851 (0%) | 0% | 85.2 | 197,865 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 291 | 16,915 (0%) | 0% | 85.3 | 24,808 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 281 | 17,206 (0%) | 0% | 85.1 | 23,902 | Common Stock |
| Bernard J. Zovighian | Director, CEO | Purchase of securities on an exchange or from another person at price $ 85.78 per share. | 03 May 2024 | 580 | 3,267 (0%) | 0% | 85.8 | 49,753 | Common Stock |
| Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 6,265 | 0 | - | - | Performance Rights | |
| Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 527 | 44,288 (0%) | 0% | 85.1 | 44,827 | Common Stock |
| Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 6,265 | 50,553 (0%) | 0% | 0 | Common Stock | |
| Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 3,718 | 46,835 (0%) | 0% | 85.3 | 316,960 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 02 May 2024 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 29,350 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 84.59 per share. | 02 May 2024 | 17,143 | 4,485 (0%) | 0% | 84.6 | 1,450,126 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 85.02 per share. | 02 May 2024 | 12,207 | 21,628 (0%) | 0% | 85.0 | 1,037,839 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 14,400 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Sale of securities on an exchange or to another person at price $ 84.11 per share. | 01 May 2024 | 12,240 | 173,848 (0%) | 0% | 84.1 | 1,029,449 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Sale of securities on an exchange or to another person at price $ 84.83 per share. | 01 May 2024 | 2,160 | 186,088 (0%) | 0% | 84.8 | 183,238 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 01 May 2024 | 14,400 | 188,248 (0%) | 0% | 36.8 | 529,200 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 30 Apr 2024 | 7,250 | 26,324 (0%) | 0% | 36.8 | 266,438 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 7,250 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.74 per share. | 30 Apr 2024 | 6,550 | 19,074 (0%) | 0% | 85.7 | 561,579 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 86.40 per share. | 30 Apr 2024 | 700 | 25,624 (0%) | 0% | 86.4 | 60,483 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 09 Apr 2024 | 857 | 18,344 (0%) | 0% | 36.8 | 31,495 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 857 | 857 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 92.34 per share. | 09 Apr 2024 | 857 | 17,487 (0%) | 0% | 92.3 | 79,135 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 92.66 per share. | 08 Apr 2024 | 100 | 52,167 (0%) | 0% | 92.7 | 9,266 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 92.33 per share. | 08 Apr 2024 | 12,400 | 39,767 (0%) | 0% | 92.3 | 1,144,876 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 08 Apr 2024 | 12,500 | 52,267 (0%) | 0% | 36.8 | 459,375 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 12,500 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Jean-Luc M. Lemercier | CVP, EMEACLA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2024 | 14,400 | 14,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Jean-Luc M. Lemercier | CVP, EMEACLA | Sale of securities on an exchange or to another person at price $ 92.32 per share. | 08 Apr 2024 | 14,293 | 173,848 (0%) | 0% | 92.3 | 1,319,558 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA | Sale of securities on an exchange or to another person at price $ 92.65 per share. | 08 Apr 2024 | 107 | 188,141 (0%) | 0% | 92.7 | 9,914 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 08 Apr 2024 | 14,400 | 188,248 (0%) | 0% | 36.8 | 529,200 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 04 Apr 2024 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 93.72 per share. | 04 Apr 2024 | 2,712 | 30,923 (0%) | 0% | 93.7 | 254,169 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 91.54 per share. | 04 Apr 2024 | 9,820 | 21,103 (0%) | 0% | 91.5 | 898,923 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 92.70 per share. | 04 Apr 2024 | 16,618 | 4,485 (0%) | 0% | 92.7 | 1,540,489 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 29,350 | 29,350 | - | - | Employee Stock Option (Right to Acquire) | |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 94.19 per share. | 04 Apr 2024 | 200 | 33,635 (0%) | 0% | 94.2 | 18,838 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 01 Apr 2024 | 7,255 | 26,329 (0%) | 0% | 36.7 | 266,621 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 7,255 | 7,250 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 94.81 per share. | 01 Apr 2024 | 6,387 | 19,074 (0%) | 0% | 94.8 | 605,521 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.51 per share. | 01 Apr 2024 | 868 | 25,461 (0%) | 0% | 95.5 | 82,903 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Mar 2024 | 14,500 | 54,002 (0%) | 0% | 36.8 | 532,875 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 14,500 | 12,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 91.01 per share. | 13 Mar 2024 | 14,500 | 39,502 (0%) | 0% | 91.0 | 1,319,696 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 14,400 | 28,800 | - | - | Employee Stock Option (Right to Acquire) | |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Sale of securities on an exchange or to another person at price $ 91.68 per share. | 11 Mar 2024 | 14,400 | 173,583 (0%) | 0% | 91.7 | 1,320,149 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 11 Mar 2024 | 14,400 | 187,983 (0%) | 0% | 36.8 | 529,200 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 90.98 per share. | 07 Mar 2024 | 1,715 | 17,213 (0%) | 0% | 91.0 | 156,031 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 1,715 | 1,714 | - | - | Employee Stock Option (Right to Acquire) | |
| Daniel J. Lippis | CVP, JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 07 Mar 2024 | 1,715 | 18,928 (0%) | 0% | 36.7 | 63,026 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 04 Mar 2024 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 29,350 | 58,700 | - | - | Employee Stock Option (Right to Acquire) | |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 87.05 per share. | 04 Mar 2024 | 16,040 | 4,485 (0%) | 0% | 87.1 | 1,396,282 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 86.21 per share. | 04 Mar 2024 | 13,310 | 20,525 (0%) | 0% | 86.2 | 1,147,455 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 7,255 | 14,505 | - | - | Employee Stock Option (Right to Acquire) | |
| B. Scott Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.59 per share. | 29 Feb 2024 | 7,255 | 19,074 (0%) | 0% | 85.6 | 620,923 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 29 Feb 2024 | 7,255 | 26,329 (0%) | 0% | 36.7 | 266,621 | Common Stock |
| Kieran Gallahue T. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.86 per share. | 23 Feb 2024 | 7,056 | 10,757 (0%) | 0% | 36.9 | 260,107 | Common Stock |
| Kieran Gallahue T. | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Feb 2024 | 7,056 | 70,277 (0%) | 0% | 0 | Common Stock | |
| Kieran T. Gallahue | Director | Sale of securities on an exchange or to another person at price $ 87.61 per share. | 23 Feb 2024 | 3,058 | 67,219 (0%) | 0% | 87.6 | 267,911 | Common Stock |
| T. Kieran Gallahue | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 7,056 | 0 | - | - | Director Stock Option (Right to Acquire) | |
| Kieran T. Gallahue | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Feb 2024 | 7,056 | 3,701 (0%) | 0% | 0 | Common Stock | |
| Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 8,560 | 43,373 (0%) | 0% | 0 | Common Stock | |
| Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 1,998 | 15,085 (0%) | 0% | 0 | Common Stock | |
| Chopra Daveen | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 86.75 per share. | 21 Feb 2024 | 7,000 | 22,750 (0%) | 0% | 86.8 | 607,268 | Common Stock |
| Daveen Chopra | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 86.67 per share. | 21 Feb 2024 | 1,200 | 29,750 (0%) | 0% | 86.7 | 104,004 | Common Stock |
| Daveen Chopra | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.26 per share. | 21 Feb 2024 | 7,000 | 30,950 (0%) | 0% | 59.3 | 414,797 | Common Stock |
| Chopra Daveen | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 7,000 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Wood L. Larry | Global President TAVR & Surg | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.04 per share. | 16 Feb 2024 | 317 | 213,476 (0%) | 0% | 86.0 | 27,275 | Common Stock |
| Daniel J. Lippis | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.10 per share. | 16 Feb 2024 | 150 | 17,401 (0%) | 0% | 86.1 | 12,915 | Common Stock |
| J. Lippis Daniel | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.10 per share. | 16 Feb 2024 | 188 | 17,213 (0%) | 0% | 86.1 | 16,187 | Common Stock |
| Ullem B. Scott | CVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.04 per share. | 16 Feb 2024 | 174 | 19,074 (0%) | 0% | 86.0 | 14,971 | Common Stock |
| Lippis Daniel J. | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.04 per share. | 16 Feb 2024 | 207 | 17,551 (0%) | 0% | 86.0 | 17,810 | Common Stock |
| E. Bobo Donald | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 86.34 per share. | 13 Feb 2024 | 470 | 50,032 (0%) | 0% | 86.3 | 40,582 | Common Stock |
| Szyman Katie | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 86.46 per share. | 13 Feb 2024 | 20,000 | 34,813 (0%) | 0% | 86.5 | 1,729,200 | Common Stock |
| Szyman Katie | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Feb 2024 | 27,000 | 61,813 (0%) | 0% | 36.8 | 992,250 | Common Stock |
| Szyman Katie | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Feb 2024 | 20,000 | 54,813 (0%) | 0% | 36.8 | 735,000 | Common Stock |
| Bobo Donald E. | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Feb 2024 | 11,000 | 50,502 (0%) | 0% | 36.8 | 404,250 | Common Stock |
| Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 85.62 per share. | 13 Feb 2024 | 27,000 | 34,813 (0%) | 0% | 85.6 | 2,311,654 | Common Stock |
| Szyman Katie | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 20,000 | 27,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Bobo E. Donald | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 11,000 | 27,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Szyman Katie | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 27,000 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 85.81 per share. | 13 Feb 2024 | 10,530 | 39,502 (0%) | 0% | 85.8 | 903,573 | Common Stock |
| W.A. Robert Sellers | SVP, Corporate Controller | Sale of securities on an exchange or to another person at price $ 87.00 per share. | 12 Feb 2024 | 12,210 | 13,087 (0%) | 0% | 87 | 1,062,270 | Common Stock |
| Sellers W.A. Robert | SVP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 12 Feb 2024 | 12,210 | 25,297 (0%) | 0% | 36.8 | 448,718 | Common Stock |
| Robert Sellers W.A. | SVP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 12,210 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Leslie Stone Heisz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 7,056 | 0 | - | - | Director Stock Option (Right to Acquire) | |
| Heisz Leslie Stone | Director | Sale of securities on an exchange or to another person at price $ 86.45 per share. | 08 Feb 2024 | 7,056 | 26,980 (0%) | 0% | 86.4 | 609,991 | Common Stock |
| Leslie Heisz Stone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.86 per share. | 08 Feb 2024 | 7,056 | 34,036 (0%) | 0% | 36.9 | 260,107 | Common Stock |
| Mussallem Michael A. | Director | Sale of securities on an exchange or to another person at price $ 86.44 per share. | 05 Feb 2024 | 9,761 | 16,652 (0%) | 0% | 86.4 | 843,741 | Common Stock |
| A. Michael Mussallem | Director | Sale of securities on an exchange or to another person at price $ 87.55 per share. | 05 Feb 2024 | 12,167 | 4,485 (0%) | 0% | 87.6 | 1,065,221 | Common Stock |
| A. Mussallem Michael | Director | Sale of securities on an exchange or to another person at price $ 88.63 per share. | 05 Feb 2024 | 6,422 | 26,413 (0%) | 0% | 88.6 | 569,182 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 05 Feb 2024 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 89.61 per share. | 05 Feb 2024 | 1,000 | 32,835 (0%) | 0% | 89.6 | 89,610 | Common Stock |
| A. Michael Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 29,350 | 88,050 | - | - | Employee Stock Option (Right to Acquire) | |
| B. Ullem Scott | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 01 Feb 2024 | 7,255 | 26,503 (0%) | 0% | 36.7 | 266,621 | Common Stock |
| Ullem B. Scott | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 7,255 | 21,760 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott Ullem B. | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 78.29 per share. | 01 Feb 2024 | 7,255 | 19,248 (0%) | 0% | 78.3 | 567,994 | Common Stock |
| Donald Bobo E. | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 10,000 | 38,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Bobo E. Donald | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 12 Jan 2024 | 10,000 | 49,502 (0%) | 0% | 36.8 | 367,500 | Common Stock |
| E. Donald Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 75.67 per share. | 12 Jan 2024 | 10,000 | 39,502 (0%) | 0% | 75.7 | 756,700 | Common Stock |
| Michael Mussallem A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 29,350 | 117,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Mussallem Michael A. | Director | Sale of securities on an exchange or to another person at price $ 72.94 per share. | 05 Jan 2024 | 26,850 | 4,485 (0%) | 0% | 72.9 | 1,958,439 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 05 Jan 2024 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Mussallem Michael A. | Director | Sale of securities on an exchange or to another person at price $ 73.46 per share. | 05 Jan 2024 | 2,500 | 31,335 (0%) | 0% | 73.5 | 183,650 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 76.55 per share. | 29 Dec 2023 | 14,510 | 19,248 (0%) | 0% | 76.6 | 1,110,794 | Common Stock |
| Ullem Scott B. | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 14,510 | 29,015 | - | - | Employee Stock Option (Right to Acquire) | |
| B. Ullem Scott | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 29 Dec 2023 | 14,510 | 33,758 (0%) | 0% | 36.8 | 533,243 | Common Stock |
| Chopra Daveen | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.26 per share. | 15 Dec 2023 | 7,000 | 30,950 (0%) | 0% | 59.3 | 414,797 | Common Stock |
| Chopra Daveen | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 78.25 per share. | 15 Dec 2023 | 7,000 | 23,950 (0%) | 0% | 78.2 | 547,724 | Common Stock |
| Daveen Chopra | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 7,000 | 7,000 | - | - | Employee Stock Option (Right to Acquire) | |
| A. Michael Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Dec 2023 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| L. Larry Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 71.86 per share. | 13 Dec 2023 | 8,658 | 213,793 (0%) | 0% | 71.9 | 622,164 | Common Stock |
| Bobo Donald E. | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 71.86 per share. | 13 Dec 2023 | 8,000 | 39,502 (0%) | 0% | 71.9 | 574,880 | Common Stock |
| A. Michael Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 29,350 | 146,750 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry Wood L. | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 8,658 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Mussallem Michael A. | Director | Sale of securities on an exchange or to another person at price $ 73.15 per share. | 13 Dec 2023 | 3,200 | 28,807 (0%) | 0% | 73.2 | 234,080 | Common Stock |
| A. Mussallem Michael | Director | Sale of securities on an exchange or to another person at price $ 75.73 per share. | 13 Dec 2023 | 1,828 | 32,007 (0%) | 0% | 75.7 | 138,434 | Common Stock |
| Bobo E. Donald | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Dec 2023 | 8,000 | 47,502 (0%) | 0% | 36.8 | 294,000 | Common Stock |
| Donald Bobo E. | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 8,000 | 48,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Mussallem Michael A. | Director | Sale of securities on an exchange or to another person at price $ 75.12 per share. | 13 Dec 2023 | 13,722 | 4,485 (0%) | 0% | 75.1 | 1,030,797 | Common Stock |
| Wood L. Larry | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Dec 2023 | 8,658 | 222,451 (0%) | 0% | 45.3 | 392,006 | Common Stock |
| A. Michael Mussallem | Director | Sale of securities on an exchange or to another person at price $ 74.22 per share. | 13 Dec 2023 | 10,600 | 18,207 (0%) | 0% | 74.2 | 786,732 | Common Stock |
| Chopra Daveen | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.26 per share. | 06 Dec 2023 | 3,500 | 27,450 (0%) | 0% | 59.3 | 207,398 | Common Stock |
| Chopra Daveen | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 3,500 | 14,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Chopra Daveen | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 06 Dec 2023 | 3,500 | 23,950 (0%) | 0% | 70.0 | 245,006 | Common Stock |
| E. Bobo Donald | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 64.72 per share. | 13 Nov 2023 | 2,300 | 43,202 (0%) | 0% | 64.7 | 148,851 | Common Stock |
| Bobo E. Donald | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2023 | 6,000 | 56,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald Bobo E. | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Nov 2023 | 6,000 | 45,502 (0%) | 0% | 36.8 | 220,500 | Common Stock |
| L. Larry Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Nov 2023 | 8,660 | 222,453 (0%) | 0% | 45.3 | 392,096 | Common Stock |
| L. Larry Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 64.68 per share. | 13 Nov 2023 | 3,158 | 219,195 (0%) | 0% | 64.7 | 204,274 | Common Stock |
| Wood Larry L. | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2023 | 8,660 | 8,658 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry Wood L. | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 65.64 per share. | 13 Nov 2023 | 5,402 | 213,793 (0%) | 0% | 65.6 | 354,565 | Common Stock |
| Bobo E. Donald | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 65.66 per share. | 13 Nov 2023 | 3,700 | 39,502 (0%) | 0% | 65.7 | 242,929 | Common Stock |
| L. Larry Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 66.21 per share. | 13 Nov 2023 | 100 | 222,353 (0%) | 0% | 66.2 | 6,621 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 03 Nov 2023 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Michael A. Mussallem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Nov 2023 | 371,689 | 0 (0%) | 0% | 0 | Common Stock | |
| Michael A. Mussallem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Nov 2023 | 371,689 | 4,038,377 (1%) | 0% | 0 | Common Stock | |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2023 | 29,350 | 176,100 | - | - | Employee Stock Option (Right to Acquire) | |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 67.18 per share. | 03 Nov 2023 | 29,350 | 4,485 (0%) | 0% | 67.2 | 1,971,733 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2023 | 7,255 | 43,525 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 31 Oct 2023 | 7,255 | 26,503 (0%) | 0% | 36.7 | 266,621 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 62.66 per share. | 31 Oct 2023 | 7,255 | 19,248 (0%) | 0% | 62.7 | 454,569 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 70.25 per share. | 13 Oct 2023 | 3,000 | 39,502 (0%) | 0% | 70.3 | 210,754 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 69.58 per share. | 13 Oct 2023 | 2,000 | 42,502 (0%) | 0% | 69.6 | 139,156 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Oct 2023 | 5,000 | 44,502 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2023 | 5,000 | 62,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2023 | 8,660 | 17,318 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 13 Oct 2023 | 8,660 | 222,453 (0%) | 0% | 45.3 | 392,096 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 69.61 per share. | 13 Oct 2023 | 3,510 | 218,943 (0%) | 0% | 69.6 | 244,334 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 70.26 per share. | 13 Oct 2023 | 5,150 | 213,793 (0%) | 0% | 70.3 | 361,864 | Common Stock |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2023 | 5,000 | 47,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 10 Oct 2023 | 5,000 | 39,813 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 72.68 per share. | 10 Oct 2023 | 5,000 | 34,813 (0%) | 0% | 72.7 | 363,400 | Common Stock |
| Daveen Chopra | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2023 | 8,500 | 17,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Daveen Chopra | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 03 Oct 2023 | 8,500 | 23,950 (0%) | 0% | 70 | 595,000 | Common Stock |
| Daveen Chopra | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.26 per share. | 03 Oct 2023 | 8,500 | 32,450 (0%) | 0% | 59.3 | 503,682 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2023 | 29,350 | 205,450 | - | - | Employee Stock Option (Right to Acquire) | |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 68.84 per share. | 02 Oct 2023 | 29,350 | 4,485 (0%) | 0% | 68.8 | 2,020,454 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 02 Oct 2023 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 69.54 per share. | 29 Sep 2023 | 7,255 | 19,248 (0%) | 0% | 69.5 | 504,527 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2023 | 7,255 | 50,780 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 29 Sep 2023 | 7,255 | 26,503 (0%) | 0% | 36.7 | 266,621 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2023 | 4,500 | 67,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 14 Sep 2023 | 4,500 | 44,002 (0%) | 0% | 36.8 | 165,375 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 73.71 per share. | 14 Sep 2023 | 4,500 | 39,502 (0%) | 0% | 73.7 | 331,695 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 14 Sep 2023 | 8,660 | 222,453 (0%) | 0% | 45.3 | 392,096 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 73.63 per share. | 14 Sep 2023 | 8,660 | 213,793 (0%) | 0% | 73.6 | 637,615 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2023 | 8,660 | 25,978 | - | - | Employee Stock Option (Right to Acquire) | |
| Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2023 | 7,262 | 7,262 (0%) | 0% | 0 | Common Stock | |
| Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2023 | 19,256 | 19,256 | - | - | Employee Stock Option (Right to Acquire) | |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 08 Sep 2023 | 5,000 | 39,813 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2023 | 5,000 | 52,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 76.00 per share. | 08 Sep 2023 | 5,000 | 34,813 (0%) | 0% | 76 | 380,000 | Common Stock |
| Daveen Chopra | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2023 | 8,500 | 26,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Daveen Chopra | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.26 per share. | 06 Sep 2023 | 8,500 | 32,450 (0%) | 0% | 59.3 | 503,682 | Common Stock |
| Daveen Chopra | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 76.07 per share. | 06 Sep 2023 | 8,500 | 23,950 (0%) | 0% | 76.1 | 646,609 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2023 | 29,350 | 234,800 | - | - | Employee Stock Option (Right to Acquire) | |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 05 Sep 2023 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 75.86 per share. | 05 Sep 2023 | 29,350 | 4,485 (0%) | 0% | 75.9 | 2,226,491 | Common Stock |
| Michael A. Mussallem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Aug 2023 | 49,766 | 4,485 (0%) | 0% | 0 | Common Stock | |
| Michael A. Mussallem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Aug 2023 | 49,766 | 3,666,688 (1%) | 0% | 0 | Common Stock | |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2023 | 7,255 | 58,035 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 31 Aug 2023 | 7,255 | 26,503 (0%) | 0% | 36.7 | 266,621 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 77.79 per share. | 31 Aug 2023 | 7,255 | 19,248 (0%) | 0% | 77.8 | 564,366 | Common Stock |
| Daveen Chopra | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 76.69 per share. | 29 Aug 2023 | 1,500 | 23,950 (0%) | 0% | 76.7 | 115,040 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 79.30 per share. | 14 Aug 2023 | 4,500 | 39,502 (0%) | 0% | 79.3 | 356,850 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2023 | 4,500 | 71,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 14 Aug 2023 | 4,500 | 44,002 (0%) | 0% | 36.8 | 165,375 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 14 Aug 2023 | 6,421 | 220,214 (0%) | 0% | 45.3 | 290,722 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2023 | 6,421 | 34,638 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 79.30 per share. | 14 Aug 2023 | 6,421 | 213,793 (0%) | 0% | 79.3 | 509,185 | Common Stock |
| Leslie Stone Heisz | Director | Sale of securities on an exchange or to another person at price $ 78.87 per share. | 10 Aug 2023 | 3,303 | 26,980 (0%) | 0% | 78.9 | 260,509 | Common Stock |
| Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 78.64 per share. | 09 Aug 2023 | 5,000 | 34,813 (0%) | 0% | 78.6 | 393,185 | Common Stock |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 5,000 | 57,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 09 Aug 2023 | 5,000 | 39,813 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 80.54 per share. | 07 Aug 2023 | 300 | 83,301 (0%) | 0% | 80.5 | 24,162 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 29,350 | 264,150 | - | - | Employee Stock Option (Right to Acquire) | |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 79.86 per share. | 07 Aug 2023 | 29,050 | 54,251 (0%) | 0% | 79.9 | 2,319,933 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 07 Aug 2023 | 29,350 | 83,601 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 84.35 per share. | 31 Jul 2023 | 7,255 | 19,248 (0%) | 0% | 84.3 | 611,959 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 31 Jul 2023 | 7,255 | 26,503 (0%) | 0% | 36.7 | 266,621 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 7,255 | 65,290 | - | - | Employee Stock Option (Right to Acquire) | |
| Bernard J. Zovighian | Director, CEO | 31 Jul 2023 | 2,558 | 47,111 (0%) | 0% | 83.6 | 213,744 | Common Stock | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 14 Jul 2023 | 3,500 | 43,002 (0%) | 0% | 36.8 | 128,625 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 3,500 | 76,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 92.94 per share. | 14 Jul 2023 | 3,500 | 39,502 (0%) | 0% | 92.9 | 325,275 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 8,660 | 41,059 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 14 Jul 2023 | 8,660 | 222,453 (0%) | 0% | 45.3 | 392,096 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 92.94 per share. | 14 Jul 2023 | 8,660 | 213,793 (0%) | 0% | 92.9 | 804,843 | Common Stock |
| Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.46 per share. | 07 Jul 2023 | 252 | 34,813 (0%) | 0% | 90.5 | 22,796 | Common Stock |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 5,000 | 62,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 90.52 per share. | 07 Jul 2023 | 5,000 | 34,813 (0%) | 0% | 90.5 | 452,600 | Common Stock |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 07 Jul 2023 | 5,000 | 39,813 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.46 per share. | 07 Jul 2023 | 81 | 173,583 (0%) | 0% | 90.5 | 7,327 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 91.22 per share. | 05 Jul 2023 | 7,622 | 75,979 (0%) | 0% | 91.2 | 695,279 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2023 | 29,350 | 293,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 90.63 per share. | 05 Jul 2023 | 21,728 | 54,251 (0%) | 0% | 90.6 | 1,969,209 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 05 Jul 2023 | 29,350 | 83,601 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 93.27 per share. | 30 Jun 2023 | 7,255 | 19,248 (0%) | 0% | 93.3 | 676,674 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 7,255 | 72,545 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 30 Jun 2023 | 7,255 | 26,503 (0%) | 0% | 36.7 | 266,621 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 3,500 | 79,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 14 Jun 2023 | 3,500 | 43,002 (0%) | 0% | 36.8 | 128,625 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 89.77 per share. | 14 Jun 2023 | 3,500 | 39,502 (0%) | 0% | 89.8 | 314,195 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2023 | 8,660 | 49,719 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 89.87 per share. | 14 Jun 2023 | 5,810 | 213,793 (0%) | 0% | 89.9 | 522,152 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 90.71 per share. | 14 Jun 2023 | 2,850 | 219,603 (0%) | 0% | 90.7 | 258,528 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 14 Jun 2023 | 8,660 | 222,453 (0%) | 0% | 45.3 | 392,096 | Common Stock |
| Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 85.81 per share. | 13 Jun 2023 | 5,000 | 35,055 (0%) | 0% | 85.8 | 429,045 | Common Stock |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 5,000 | 67,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Jun 2023 | 5,000 | 40,055 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 29,350 | 322,850 | - | - | Employee Stock Option (Right to Acquire) | |
| Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 01 Jun 2023 | 29,350 | 115,559 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 83.43 per share. | 01 Jun 2023 | 5,300 | 110,259 (0%) | 0% | 83.4 | 442,179 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 85.08 per share. | 01 Jun 2023 | 5,396 | 104,863 (0%) | 0% | 85.1 | 459,092 | Common Stock |
| Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 84.57 per share. | 01 Jun 2023 | 18,654 | 86,209 (0%) | 0% | 84.6 | 1,577,569 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Sale of securities on an exchange or to another person at price $ 84.23 per share. | 24 May 2023 | 6,421 | 213,793 (0%) | 0% | 84.2 | 540,841 | Common Stock |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 6,421 | 58,379 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | Global President TAVR & Surg | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 24 May 2023 | 6,421 | 220,214 (0%) | 0% | 45.3 | 290,722 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 May 2023 | 8,496 | 266,318 (0%) | 0% | 0 | Common Stock | |
| Scott B. Ullem | CVP, Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 May 2023 | 8,496 | 19,248 (0%) | 0% | 0 | Common Stock | |
| Kieran T. Gallahue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 2,803 | 2,803 (0%) | 0% | 0 | Common Stock | |
| Kieran T. Gallahue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 898 | 3,701 (0%) | 0% | 0 | Common Stock | |
| Michael A. Mussallem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 4,485 | 86,209 (0%) | 0% | 0 | Common Stock | |
| Michael A. Mussallem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 3,589 | 3,589 | - | - | Director Stock Option (Right to Acquire) | |
| Nicholas J. Valeriani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 2,803 | 68,914 (0%) | 0% | 0 | Common Stock | |
| Paul A. Laviolette | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 2,803 | 7,718 (0%) | 0% | 0 | Common Stock | |
| Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 2,803 | 55,420 (0%) | 0% | 0 | Common Stock | |
| Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 898 | 56,318 (0%) | 0% | 0 | Common Stock | |
| Leslie Stone Heisz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 2,803 | 30,283 (0%) | 0% | 0 | Common Stock | |
| Leslie Stone Heisz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 1,795 | 1,795 | - | - | Director Stock Option (Right to Acquire) | |
| Martha H. Marsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 2,803 | 31,880 (0%) | 0% | 0 | Common Stock | |
| Ramona Sequeira | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 2,803 | 5,103 (0%) | 0% | 0 | Common Stock | |
| Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 8,175 | 8,175 | - | - | Performance Rights | |
| Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 50,400 | 50,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 6,525 | 35,055 (0%) | 0% | 0 | Common Stock | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 8,025 | 8,025 | - | - | Performance Rights | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 6,425 | 39,502 (0%) | 0% | 0 | Common Stock | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 54,200 | 54,200 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 65,700 | 65,700 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 9,725 | 9,725 | - | - | Performance Rights | |
| Larry L. Wood | Global President TAVR & Surg | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 7,775 | 213,793 (0%) | 0% | 0 | Common Stock | |
| Scott B. Ullem | CVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 9,450 | 27,744 (0%) | 0% | 0 | Common Stock | |
| Scott B. Ullem | CVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 11,825 | 11,825 | - | - | Performance Rights | |
| Scott B. Ullem | CVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 72,900 | 72,900 | - | - | Employee Stock Option (Right to Acquire) | |
| Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 5,540 | 5,540 | - | - | Employee Stock Option (Right to Acquire) | |
| Robert W.A. Sellers | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 1,800 | 13,035 (0%) | 0% | 0 | Common Stock | |
| Bernard J. Zovighian | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 28,150 | 28,150 | - | - | Performance Rights | |
| Bernard J. Zovighian | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 22,525 | 44,552 (0%) | 0% | 0 | Common Stock | |
| Bernard J. Zovighian | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 173,700 | 173,700 | - | - | Employee Stock Option (Right to Acquire) | |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 1,975 | 1,975 | - | - | Performance Rights | |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 13,300 | 13,300 | - | - | Employee Stock Option (Right to Acquire) | |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 1,575 | 173,664 (0%) | 0% | 0 | Common Stock | |
| Daveen Chopra | CVP, TMTT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 8,100 | 8,100 | - | - | Performance Rights | |
| Daveen Chopra | CVP, TMTT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 6,475 | 25,450 (0%) | 0% | 0 | Common Stock | |
| Daveen Chopra | CVP, TMTT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 49,900 | 49,900 | - | - | Employee Stock Option (Right to Acquire) | |
| Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 89.22 per share. | 10 May 2023 | 2,500 | 33,077 (0%) | 0% | 89.2 | 223,050 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 10 May 2023 | 2,500 | 35,577 (0%) | 0% | 36.8 | 91,875 | Common Stock |
| Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2023 | 2,500 | 83,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2023 | 80,700 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.36 per share. | 10 May 2023 | 64,119 | 18,294 (0%) | 0% | 88.4 | 5,665,619 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 89.22 per share. | 10 May 2023 | 16,581 | 82,413 (0%) | 0% | 89.2 | 1,479,385 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 10 May 2023 | 80,700 | 98,994 (0%) | 0% | 35.2 | 2,840,374 | Common Stock |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 4,708 | 1,292 | - | - | Performance Rights | |
| Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 88.94 per share. | 07 May 2023 | 75,600 | 28,530 (0%) | 0% | 88.9 | 6,724,234 | Common Stock |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 07 May 2023 | 75,600 | 104,130 (0%) | 0% | 35.2 | 2,660,871 | Common Stock |
| Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 1,376 | 28,530 (0%) | 0% | 88.7 | 122,106 | Common Stock |
| Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 2,154 | 29,906 (0%) | 0% | 88.7 | 191,146 | Common Stock |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 4,708 | 32,060 (0%) | 0% | 0 | Common Stock | |
| Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 75,600 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Larry L. Wood | CVP & Grp President TAVR & SSH | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 1,472 | 206,310 (0%) | 0% | 88.7 | 130,625 | Common Stock |
| Larry L. Wood | CVP & Grp President TAVR & SSH | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 5,415 | 210,365 (0%) | 0% | 0 | Common Stock | |
| Larry L. Wood | CVP & Grp President TAVR & SSH | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 5,415 | 1,485 | - | - | Performance Rights | |
| Larry L. Wood | CVP & Grp President TAVR & SSH | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 2,583 | 207,782 (0%) | 0% | 88.7 | 229,215 | Common Stock |
| Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 20,777 | 5,698 | - | - | Performance Rights | |
| Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 20,777 | 81,724 (0%) | 0% | 0 | Common Stock | |
| Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 07 May 2023 | 29,375 | 111,099 (0%) | 0% | 35.2 | 1,033,903 | Common Stock |
| Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 88.94 per share. | 07 May 2023 | 5,984 | 105,115 (0%) | 0% | 88.9 | 532,217 | Common Stock |
| Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2023 | 9,500 | 95,615 (0%) | 0% | 0 | Common Stock | |
| Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 88.29 per share. | 07 May 2023 | 13,891 | 81,724 (0%) | 0% | 88.3 | 1,226,436 | Common Stock |
| Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2023 | 9,500 | 3,616,922 (1%) | 0% | 0 | Common Stock | |
| Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 29,375 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Scott B. Ullem | CVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 1,674 | 18,294 (0%) | 0% | 88.7 | 148,551 | Common Stock |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 6,062 | 1,663 | - | - | Performance Rights | |
| Scott B. Ullem | CVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 6,062 | 22,972 (0%) | 0% | 0 | Common Stock | |
| Scott B. Ullem | CVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 3,004 | 19,968 (0%) | 0% | 88.7 | 266,575 | Common Stock |
| Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 134 | 11,396 (0%) | 0% | 88.7 | 11,891 | Common Stock |
| Robert W.A. Sellers | SVP, Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 161 | 11,235 (0%) | 0% | 88.7 | 14,287 | Common Stock |
| Bernard J. Zovighian | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 1,433 | 22,027 (0%) | 0% | 88.7 | 127,164 | Common Stock |
| Bernard J. Zovighian | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 2,323 | 23,460 (0%) | 0% | 88.7 | 206,143 | Common Stock |
| Bernard J. Zovighian | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 5,003 | 25,783 (0%) | 0% | 0 | Common Stock | |
| Bernard J. Zovighian | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 5,003 | 1,372 | - | - | Performance Rights | |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 224 | 172,193 (0%) | 0% | 88.7 | 19,878 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 104 | 172,089 (0%) | 0% | 88.7 | 9,229 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 07 May 2023 | 6,640 | 178,729 (0%) | 0% | 35.2 | 233,706 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Sale of securities on an exchange or to another person at price $ 88.68 per share. | 07 May 2023 | 6,640 | 172,089 (0%) | 0% | 88.7 | 588,835 | Common Stock |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 3,355 | 920 | - | - | Performance Rights |